- Home
- XXII vs NBY Comparison
XXII vs NBY Comparison
Compare XXII & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XXII
- NBY
- Stock Information
- Founded
- XXII 1998
- NBY 2000
- Country
- XXII United States
- NBY United States
- Employees
- XXII N/A
- NBY N/A
- Industry
- XXII Medicinal Chemicals and Botanical Products
- NBY
- Sector
- XXII Health Care
- NBY
- Exchange
- XXII Nasdaq
- NBY Nasdaq
- Market Cap
- XXII 6.2M
- NBY 6.3M
- IPO Year
- XXII N/A
- NBY 2007
- Fundamental
- Price
- XXII $1.52
- NBY $1.18
- Analyst Decision
- XXII
- NBY Strong Buy
- Analyst Count
- XXII 0
- NBY 1
- Target Price
- XXII N/A
- NBY $0.85
- AVG Volume (30 Days)
- XXII 1.2M
- NBY 466.6K
- Earning Date
- XXII 11-04-2025
- NBY 11-10-2025
- Dividend Yield
- XXII N/A
- NBY N/A
- EPS Growth
- XXII N/A
- NBY N/A
- EPS
- XXII N/A
- NBY 0.41
- Revenue
- XXII $21,362,000.00
- NBY $9,781,000.00
- Revenue This Year
- XXII N/A
- NBY $23.91
- Revenue Next Year
- XXII $126.57
- NBY $32.05
- P/E Ratio
- XXII N/A
- NBY $3.11
- Revenue Growth
- XXII N/A
- NBY 113.47
- 52 Week Low
- XXII $1.43
- NBY $0.46
- 52 Week High
- XXII $394.02
- NBY $4.44
- Technical
- Relative Strength Index (RSI)
- XXII 42.76
- NBY 45.81
- Support Level
- XXII $1.48
- NBY $1.17
- Resistance Level
- XXII $1.80
- NBY $1.31
- Average True Range (ATR)
- XXII 0.09
- NBY 0.14
- MACD
- XXII 0.02
- NBY 0.02
- Stochastic Oscillator
- XXII 10.81
- NBY 49.43
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.